Literature DB >> 13965101

The excretion of pethidine and its derivatives.

A M ASATOOR, D R LONDON, M D MILNE, M L SIMENHOFF.   

Abstract

The excretion of pethidine and its metabolite norpethidine is increased in acid urine and decreased in alkaline urine. Excretion of these two bases is the main route of removal of pethidine from the body if the urine is highly acid. If the urine is alkaline, excretion of the hydrolysis products meperidinic and normeperidinic acids, both as free acids and as conjugates, is the more important means of elimination of the drug. Acidification of the urine with ammonium chloride is indicated in the therapy of cases of pethidine poisoning in patients with reduced metabolic breakdown of the drug by the microsomal enzyme systems within liver cells. Reversed-phase chromatography of the dinitrophenyl derivative of norpethidine may prove to be of forensic importance in the diagnosis of pethidine poisoning or of pethidine addiction. Norpethidine can be detected in the urine by this method for at least 3 days after the last dose of pethidine. Analytical sensitivity is increased by acidification of the urine which produces a temporary rise of the excretion rate.

Entities:  

Keywords:  MEPERIDINE

Mesh:

Substances:

Year:  1963        PMID: 13965101      PMCID: PMC1703639          DOI: 10.1111/j.1476-5381.1963.tb01468.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  28 in total

1.  Amines in blood and urine in relation to liver disease.

Authors:  A M ASATOOR; D N KERR
Journal:  Clin Chim Acta       Date:  1961-03       Impact factor: 3.786

2.  A study, by simultaneous clearance techniques, of salicylate excretion in man: effect of alkalinization of the urine by bicarbonate administration; effect of probenecid.

Authors:  A GUTMAN; T F YU; J H SIROTA
Journal:  J Clin Invest       Date:  1955-05       Impact factor: 14.808

3.  Renal tubular secretion and reabsorption of organic bases in the dog.

Authors:  J TORRETTI; I M WEINER; G H MUDGE
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

4.  On the mechanism of action of probenecid on renal tubular secretion.

Authors:  I M WEINER; J A WASHINGTON; G H MUDGE
Journal:  Bull Johns Hopkins Hosp       Date:  1960-06

5.  Toxic effects of iproniazid in a patient with angina.

Authors:  C PAPP; S BENAIM
Journal:  Br Med J       Date:  1958-11-01

6.  The excretion of indolylacetic acid and related indolic acids in man and the rat.

Authors:  M D MILNE; M A CRAWFORD; C B GIRAO; L LOUGHRIDGE
Journal:  Clin Sci       Date:  1960-02       Impact factor: 6.124

7.  Renal excretion of 5,5-dimethyl-2-4-oxazolidinedione (product of demethylation of trimethadione.

Authors:  W J WADDELL; T C BUTLER
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

8.  THE INFLUENCE OF ORALLY ADMINISTERED ALKALI AND ACID ON THE RENAL EXCRETION OF QUINACRINE, CHLOROQUINE AND SANTOQUINE.

Authors:  J W Jailer; M Rosenfeld; J A Shannon
Journal:  J Clin Invest       Date:  1947-11       Impact factor: 14.808

9.  The metabolism of N-C14H3 labeled meperidine.

Authors:  N P PLOTNIKOFF; H W ELLIOTT; E L WAY
Journal:  J Pharmacol Exp Ther       Date:  1952-04       Impact factor: 4.030

10.  The physiological disposition and fate of meperidine (demerol) in man and a method for its estimation in plasma.

Authors:  J J BURNS; B L BERGER; P A LIEF; A WOLLACK; E M PAPPER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1955-07       Impact factor: 4.030

View more
  16 in total

1.  NEW APPROACHES TO POISONING. POTENTIATION OF EXCRETION OF DRUGS.

Authors:  M D MILNE
Journal:  Proc R Soc Med       Date:  1964-09

2.  PETHIDINE POISONING.

Authors:  J VINNICOMBE
Journal:  Br Med J       Date:  1963-10-05

3.  THE EXCRETION OF DEXAMPHETAMINE AND ITS DERIVATIVES.

Authors:  A M ASATOOR; B R GALMAN; J R JOHNSON; M D MILNE
Journal:  Br J Pharmacol Chemother       Date:  1965-02

4.  The effect of ageing on plasma pethidine concentration.

Authors:  K Chan; M J Kendall; M Mitchard; W D Wells
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

5.  [Not Available].

Authors:  P Löhmer; W Tolksdorf
Journal:  Schmerz       Date:  1989-03       Impact factor: 1.107

Review 6.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of pethidine.

Authors:  L E Mather; P J Meffin
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

8.  Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

Review 9.  Codeine and its alternates for pain and cough relief. 2. Alternates for pain relief.

Authors:  N B Eddy; H Friebel; K J Hahn; H Halbach
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

10.  Simultaneous determination of therapeutic plasma concentrations of pethidine and norpethidine in man by electron capture gas chromatography.

Authors:  P Hartvig; K E Karlsson; C Lindbert; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.